A randomized, double-blind, placebo-controlled, multicenter parallel group phase III study Measuring Effects on intima media Thickness: an Evaluation Of Rosuvastatin 40 mg (METEOR).
Phase of Trial: Phase III
Latest Information Update: 18 Nov 2010
At a glance
- Drugs Rosuvastatin (Primary)
- Indications Atherosclerosis
- Focus Pharmacodynamics; Therapeutic Use
- Acronyms METEOR
- 31 Aug 2018 Biomarkers information updated
- 13 Oct 2009 Actual end date (May 2006) added as reported by ClinicalTrials.gov.
- 28 Mar 2007 Results have been published.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History